patent/MY-159626-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-159626-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd1c887dd7e0e8b89dc861744eb87c89
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
filingDate	2010-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ad14eb1ac04395dd2ebe74f39098981
publicationDate	2017-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	MY-159626-A
titleOfInvention	Role of n-2-hydroxy-ethyl-piperazine-n'-2-ethane sulfonic acid (hepes) in pain control and reversal of demyelinization injury
abstract	COMPOSITIONS AND THERAPEUTIC USES OF HEPES AND DERIVATIVES IN THE TREATMENT OF PAIN ASSOCIATED WITH CANCERS AND SIDE-EFFECTS INCLUDING POST-CHEMOTHERAPY COGNITIVE IMPAIRMENT ARE DISCLOSED HEREIN. HEPES IS ALSO USED TO TREAT NEURODEGENERATIVE AND NEUROLOGICAL DISEASES, DEMYELIZATION INJURIES, AND SIDE-EFFECTS AND WITHDRAWAL SYMPTOMS ASSOCIATED WITH BENZODIAZEPINES, ANTI-DEPRESSANTS, AND OTHER NEUROLOGICAL AGENTS.
priorityDate	2009-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527052 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830

Total number of triples: 31.